Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$7.2 - $9.47 $2.06 Million - $2.71 Million
285,891 Added 941.24%
316,265 $2.38 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $469,305 - $638,277
-56,137 Reduced 64.89%
30,374 $268,000
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $687,762 - $820,124
86,511 New
86,511 $788,000
Q2 2022

Aug 09, 2022

SELL
$7.38 - $10.4 $39,490 - $55,650
-5,351 Reduced 45.46%
6,420 $48,000
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $86,281 - $110,529
11,771 New
11,771 $110,000
Q2 2021

Aug 12, 2021

SELL
$9.9 - $11.56 $166,468 - $194,381
-16,815 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $15,458 - $19,150
-1,495 Reduced 8.16%
16,815 $194,000
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $62,319 - $79,907
7,238 Added 65.37%
18,310 $176,000
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $65,646 - $97,205
7,660 Added 224.5%
11,072 $99,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $20,202 - $32,642
-2,488 Reduced 42.17%
3,412 $42,000
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $39,471 - $79,355
5,900 New
5,900 $52,000
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $144,365 - $236,997
-22,108 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $361,585 - $563,510
-58,699 Reduced 72.64%
22,108 $152,000
Q2 2019

Aug 13, 2019

BUY
$8.12 - $15.72 $656,152 - $1.27 Million
80,807 New
80,807 $745,000
Q4 2017

Feb 12, 2018

SELL
$11.23 - $19.1 $617,391 - $1.05 Million
-54,977 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $847,195 - $1.77 Million
54,977
54,977 $967,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.